1  dose of the neuromuscular facilitatory drug edrophonium.

2                                              Edrophonium (10 mg) had no significant effect on action

3 ompounds, establishes a relationship between edrophonium acceleration of oxime-induced reactivation o

4 eterminant, as characterized with respect to edrophonium and decamethonium.

5 jects with a positive chest pain response to edrophonium and in none of the 5 subjects with a negativ

6  the binding of classical inhibitors such as edrophonium and propidium or inhibitors that are current

7  subjects (before and after 80 microgm/kg of edrophonium), and under 3 study conditions in the NCE pa

8  the binding of ligands such as huperzine A, edrophonium, and acridines and one end of bisquaternary

9 ted esophageal chest pain were studied after edrophonium chloride injection to provoke symptoms.

10                 The weakness was reversed by edrophonium, consistent with a myasthenic disorder.

11                                              Edrophonium, decamethonium, and propidium, three quatern

12 e, 9-amino-1,2,3,4-tetrahydroacridine (THA), edrophonium (EDR), and other structurally diverse inhibi

13 l cord to the acetylcholinesterase inhibitor edrophonium (EDR).

14 med as, mostly strong, substrates, including edrophonium, fenpiverinium, ritodrine, and ractopamine.

15                          In normal subjects, edrophonium induced an increase in the CM and LM contrac

16 sm of the post-tetanic potentiation (PTP) or edrophonium-induced facilitatory response involves the o

17 mol/L if diagnosis was confirmed by positive edrophonium or abnormal repetitive nerve stimulation, or

18 Furthermore, when the acylation site ligands edrophonium or m-(N, N,N-trimethylammonio)trifluoroaceto

19 ed a dose-related suppression of PTP and the edrophonium response indicative of a suppression of moto

20                                           An edrophonium test revealed improvement in muscle strength

21 ide showed that in the presence of 50 microM edrophonium, the reactivation rate constants increased 3